Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC

Supported by an independant educational grant from Gilead Sciences Inc.

Part 1: The Link Between HIV and Substance Abuse

Dr. Glenn Treisman and Dr. Kathleen Brady discuss the struggle between addiction and HIV. Appropriate treatment begins with screening and diagnosis, overcoming barriers to treatment and adherence, and collaboration between caregivers. Just as important are efforts to prevent HIV infection, and there are now new tools that can help in this effort. Dr. Treisman begins by introducing a bright young man named Jason who struggled with addiction to opioids. Listen as they are joined by Dr. Marc Fishman, who discusses HIV in the setting of addiction and the importance of overcoming barriers, and Dr. Michael Saag, who discusses preventive measures.

Post-Test

Part 2: Approaches to Treatment

Dr. Glenn Treisman and Dr. Kathleen Brady discuss approaches to the treatment of HIV infection. New therapies have changed HIV infection from a death sentence to a manageable chronic disease for most patients. Listen as they are joined by Dr. Richard Moore, who discusses how available therapies affect HIV.

Post-Test

Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC

Supported by an independant educational grant from Gilead Sciences Inc.

More than 1.1 million people in the U.S. are living with HIV today, and 1 in 7 of them don’t know it.

Screening for HIV in the addiction medicine setting is vital, as is overcoming the barriers that get in your way. You can stop HIV in its tracks.

HIV treatments are highly effective, but only when they are taken properly. Do your part to reduce the morbidity and mortality associated with HIV.

Tune in to the START HIV Radio Hour to listen and learn as our expert faculty explore these important topics using patient stories and modeled after the famous and popular TED Talks.

    Learn about:
  • The importance of pre-exposure prophylaxis
  • How collaborative care can improve screening and treatment
  • Barriers to adherence and how to overcome them

The expert panel includes Glenn Treisman, MD, Director of AIDS Psychiatry Services, The Johns Hopkins University School of Medicine; Kathleen Brady, Distinguished University Professor at the Medical University of South Carolina; Marc Fishman, MD, Medical Director of Maryland Treatment Centers; Michael Saag, MD, Professor of Medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham; and Richard Moore, MD, Professor of Medicine at Johns Hopkins University School of Medicine.

Start Program

Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC

Supported by an independant educational grant from Gilead Sciences Inc.

Program Directors

Glenn Jordan Treisman, MD, PhD

Eugene Meyer III Professor of Psychiatry and Medicine
Director, AIDS Psychiatry Services
Co-Director, Chronic Pain Treatment Program
The Johns Hopkins University School of Medicine
Baltimore, Maryland


Kathleen T. Brady, MD, PhD

Distinguished University Professor
Vice President for Research
Director, South Carolina Clinical and Translational Research Institute
Medical University of South Carolina
Charleston, South Carolina

Faculty

Marc J. Fishman, MD

Assistant Professor
Johns Hopkins University School of Medicine
Medical Director, Mountain Manor Treatment Centers
Baltimore, Maryland


Michael S. Saag, MD

Professor, Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, Alabama


Richard Moore, MD, MHS

Professor of Medicine
Director, Moore Clinical for HIV Care
Divisions of Infectious Diseases and Clinical Pharmacology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC

Supported by an independant educational grant from Gilead Sciences Inc.

CME/CE

Accreditation Information

Target Audience

This activity has been designed to meet the educational needs of clinicians interested in addiction medicine.

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBmed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates these enduring activities for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Social Worker Credit Designation

Part 1: This program was approved for .5 General contact hour(s) of continuing education credit by the National Association of Social Workers—Louisiana Chapter as authorized by the Louisiana State Board of Social Work Examiners.

Part 2: This program was approved for .5 General contact hour(s) of continuing education credit by the National Association of Social Workers—Louisiana Chapter as authorized by the Louisiana State Board of Social Work Examiners.

Estimated time to complete each activity: 0.5 hours (1.0 hours total)

Educational Objectives

After completing this activity, the participant should be better able to:

    Part 1:
  • Discuss how the opioid epidemic is shifting the demographic of patients at risk for contracting HIV.
  • Identify, screen and test patients for HIV based on personal history and PWID status.
  • Describe the benefits of the use of PrEP in high-risk patients who are not yet HIV positive.
    Part 2:
  • Integrate providers from other areas (such as mental health) to provide collaborative care to overcome barriers in identifying and treating HIV.
  • Compare the safety and efficacy of new therapies with older therapies.
  • Discuss the importance of adherence to PrEP and HIV treatment.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Faculty / Presenter Reported Financial Relationship

    Glenn Jordan Treisman, MD, PhD
  • None
    Kathleen T. Brady, MD, PhD
  • None
    Marc J. Fishman, MD
  • Consulting Fees: US WorldMeds, Alkermes
  • Contracted Research: MediaRez, US World Media
  • Research Grant Support: Arnold Foundation
    Michael S. Saag, MD
  • Consulting Fees: Merck & Co. Inc., Bristol-Myers Squibb, Gilead Sciences, Inc., ViiV Healthcare, Proteus
  • Contracted Research: Merck & Co., Inc., Bristol-Myers Squibb, Gilead Sciences, Inc., ViiV Halthcare, Proteus
    Richard Moore, MD, MHS
  • Consulting Fees: Medscape

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following DKB planners and managers Stan Pogroszewski, and Rachel Deerr hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation and Request for Credit

There are no fees for participation in this CME activity. To receive credit, participants must 1) read the learning objectives and disclosure statements, 2) complete the educational activity and 3) complete the post-test and activity evaluation form, including the certificate information section. Physicians and social workers must attest to the amount of time they spent on the activity.

Enduring Materials

  • Physician (CME) Release Date: 12/21/17
  • Physician (CME) Expiration date: 12/20/19
  • Social Worker Release Date: 2/1/18
  • Social Worker Expiration Date: 2/1/19

Hardware & Software Requirements

PC: Internet Explorer (v9 or greater), Chrome or Firefox
MAC: Safari
Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.

Copyright © 2017. PIM and START: HIV
Presented by PIM in collaboration with DKBmed